Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT04963153
Title Testing Combination Erdafitinib and Enfortumab Vedotin in Metastatic Bladder Cancer After Treatment With Chemotherapy and Immunotherapy
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors National Cancer Institute (NCI)
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Los Angeles General Medical Center RECRUITING Los Angeles California 90033 United States Details
USC / Norris Comprehensive Cancer Center RECRUITING Los Angeles California 90033 United States Details
UCHealth University of Colorado Hospital SUSPENDED Aurora Colorado 80045 United States Details
Moffitt Cancer Center RECRUITING Tampa Florida 33612 United States Details
Ohio State University Comprehensive Cancer Center SUSPENDED Columbus Ohio 43210 United States Details
University of Pittsburgh Cancer Institute (UPCI) RECRUITING Pittsburgh Pennsylvania 15232 United States Details
UT Southwestern/Simmons Cancer Center-Dallas RECRUITING Dallas Texas 75390 United States Details
Huntsman Cancer Institute/University of Utah SUSPENDED Salt Lake City Utah 84112 United States Details
*Shaded cells indicate that there was no data available from for the field